Theraclion SA (ALTHE.PA) has a MoatMap StockRank of 38/100 based on Quality (27/100), Value (45/100), and Momentum (53/100) factor scores. The current signal is HOLD. Theraclion is a French micro-cap medical device company developing echotherapy systems. It lacks scale, financial viability, and any connection to our high-conviction macro themes, making it highly unsuitable for a concentrated institutional book.
Theraclion SA is a French medical device company that designs, develops, and markets innovative robotic platforms for non-invasive echotherapy using High-Intensity Focused Ultrasound (HIFU). The company's competitive advantage is anchored in its proprietary SONOVEIN and Echopulse systems, which offer non-surgical alternatives for treating varicose veins and thyroid nodules. It is a pioneering niche player in the therapeutic ultrasound market, expanding its commercial footprint across Europe and Asia.
| Price | $0.89 |
| Market Cap | $59M |
| P/E (Forward) | 8.30 |
| Price/Book | -19.30 |
| Gross Margin | 0.0% |
| Operating Margin | 1688.4% |
| Free Cash Flow | $-9M |
Theraclion SA operates in the Medical Devices industry, part of the Healthcare sector (France).